P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
A. Bessudo,
D. Greenwald,
M. H. Kazemi,
A. Mahindra,
L. Shunyakov,
M. Sondhi,
H. O’Connor,
Y. Chen,
J. Yang,
G. Salles
Affiliations
A. Bessudo
1 cCare, Encinitas
D. Greenwald
2 UCLA, Santa Barbara
M. H. Kazemi
3 Astera Cancer Care, East Brunswick
A. Mahindra
4 Scripps MD Anderson Cancer Center, La Jolla
L. Shunyakov
5 Central Care Cancer Center, Bolivar
M. Sondhi
6 Epizyme, Inc., Cambridge
H. O’Connor
6 Epizyme, Inc., Cambridge
Y. Chen
6 Epizyme, Inc., Cambridge
J. Yang
6 Epizyme, Inc., Cambridge
G. Salles
7 Memorial Sloan Kettering Cancer Center, New York, United States of America